- Home
- ACV vs SMTI Comparison
ACV vs SMTI Comparison
Compare ACV & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACV
- SMTI
- Stock Information
- Founded
- ACV 2015
- SMTI 1982
- Country
- ACV United States
- SMTI United States
- Employees
- ACV N/A
- SMTI N/A
- Industry
- ACV Finance/Investors Services
- SMTI Medical/Dental Instruments
- Sector
- ACV Finance
- SMTI Health Care
- Exchange
- ACV Nasdaq
- SMTI Nasdaq
- Market Cap
- ACV 234.1M
- SMTI 243.3M
- IPO Year
- ACV N/A
- SMTI N/A
- Fundamental
- Price
- ACV $23.47
- SMTI $33.57
- Analyst Decision
- ACV
- SMTI Strong Buy
- Analyst Count
- ACV 0
- SMTI 2
- Target Price
- ACV N/A
- SMTI $50.00
- AVG Volume (30 Days)
- ACV 38.8K
- SMTI 39.3K
- Earning Date
- ACV 01-01-0001
- SMTI 08-13-2025
- Dividend Yield
- ACV 9.20%
- SMTI N/A
- EPS Growth
- ACV N/A
- SMTI N/A
- EPS
- ACV N/A
- SMTI N/A
- Revenue
- ACV N/A
- SMTI $97,241,894.00
- Revenue This Year
- ACV N/A
- SMTI $24.49
- Revenue Next Year
- ACV N/A
- SMTI $14.43
- P/E Ratio
- ACV N/A
- SMTI N/A
- Revenue Growth
- ACV N/A
- SMTI 34.29
- 52 Week Low
- ACV $16.82
- SMTI $23.53
- 52 Week High
- ACV $23.74
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- ACV 69.25
- SMTI 61.67
- Support Level
- ACV $22.95
- SMTI $32.35
- Resistance Level
- ACV $23.20
- SMTI $34.71
- Average True Range (ATR)
- ACV 0.26
- SMTI 1.36
- MACD
- ACV 0.07
- SMTI 0.13
- Stochastic Oscillator
- ACV 100.00
- SMTI 72.56
About ACV Virtus Diversified Income & Convertible Fund of Beneficial Interest
Virtus AllianzGI Diversified Income & Convertible Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation while seeking to provide downside protection against capital loss. It invests in a diversified portfolio of convertible securities, income-producing equity securities, and income-producing debt and other instruments of varying maturities, of which a majority of the managed assets are invested in convertibles.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.